| |
| |
|
| Insider
Information: |
Meckler Jeffrey A |
| Relationship: |
CEO and Director, Dire... |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
920,535 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,333,383 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
920,535 |
|
|
| Total
Value |
$2,333,383 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
8
|
0
|
|
Stock
price went up :
|
2
|
0
|
| Stock
price went down : |
6
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -24.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Novelion Therapeutics Inc |
NVLN |
Director |
2015-06-29 |
107,000 |
2013-05-03 |
0 |
Premium* |
|
|
Travere Therapeutics, Inc |
TVTX |
|
2024-05-08 |
81,000 |
2014-10-08 |
0 |
Premium* |
|
|
Cocrystal Pharma |
COCP |
|
2016-03-15 |
657,161 |
2014-12-11 |
0 |
Premium* |
|
|
Intec Parent Inc. |
INDP |
CEO and Director, Dire... |
2022-11-21 |
75,374 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
33 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TVTX |
Travere Therapeutics, Inc |
Director |
– • – |
2014-10-08 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
20,000 |
0 |
- |
|
| NVLN |
Novelion Therapeutics Inc |
Director |
– • – |
2014-12-18 |
4 |
B |
$3.60 |
$72,000 |
D/D |
20,000 |
72,000 |
2.39 |
- |
|
| NVLN |
Novelion Therapeutics Inc |
Director |
– • – |
2015-06-29 |
4 |
OE |
$3.30 |
$87,125 |
D/D |
25,000 |
107,000 |
0 |
- |
|
| NVLN |
Novelion Therapeutics Inc |
Director |
– • – |
2013-06-28 |
4 |
B |
$4.36 |
$130,800 |
D/D |
30,000 |
50,000 |
2.39 |
- |
|
| COCP |
Cocrystal Pharma |
|
– • – |
2014-12-11 |
4 |
B |
$0.45 |
$45,610 |
D/D |
100,000 |
100,000 |
2.39 |
- |
|
| COCP |
Cocrystal Pharma |
CHIEF EXECUTIVE OFFICER |
• • – |
2015-12-23 |
4 |
B |
$0.58 |
$57,870 |
D/D |
100,000 |
363,043 |
2.81 |
- |
|
| COCP |
Cocrystal Pharma |
|
– • – |
2015-03-25 |
4 |
B |
$0.92 |
$150,000 |
D/D |
163,043 |
263,043 |
2.39 |
- |
|
| COCP |
Cocrystal Pharma |
CHIEF EXECUTIVE OFFICER |
• • – |
2016-03-15 |
4 |
B |
$0.51 |
$150,000 |
D/D |
294,118 |
657,161 |
2.81 |
- |
|
33 Records found
|
|
Page 2 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
